...
首页> 外文期刊>Journal of Cardiothoracic Surgery >Clinical course and outcome of patients with acute pulmonary embolism rescued by veno-arterial extracorporeal membrane oxygenation: a retrospective review of 21 cases
【24h】

Clinical course and outcome of patients with acute pulmonary embolism rescued by veno-arterial extracorporeal membrane oxygenation: a retrospective review of 21 cases

机译:静脉动脉体外膜氧源性急性肺栓塞患者临床课程及结果:21例回顾性综述

获取原文
           

摘要

Veno-arterial extracorporeal membrane oxygenation (ECMO) is increasingly being utilized in patients with massive pulmonary embolism (PE). However, the efficacy and the safety remain uncertain. This study aimed to investigate clinical courses and outcomes in ECMO-treated patients with acute PE. Twenty-one patients with acute PE rescued by ECMO from January 2012 to December 2019 were retrospectively analysed. Clinical features, laboratory biomarkers, and imaging findings of these patients were reviewed, and the relationship with immediate outcome and clinical course was investigated. Sixteen patients (76.2%) experienced refractory circulatory collapse requiring cardiopulmonary resuscitation (CPR) or ECMO support within 2?h after the onset of cardiogenic shock, and none could receive definitive reperfusion therapy before ECMO initiation. Before or during ECMO support, more than 90% of patients had imaging signs of right ventricular (RV) dysfunction. In normotension patients, the computed tomography (CT) value was a valuable predictor of rapid disease progression compared with cardiac troponin I level. Ultimately, in-hospital death occurred in ten patients (47.6%) and 90% of them died of prolonged CPR-related brain death. Cardiac arrest was a significant predictor of poor prognosis (p?=?0.001). ECMO appears to be a safe and effective circulatory support in patients with massive PE. Close monitoring in intensive care unit is recommended in patients with RV dysfunction and aggressive use of ECMO may reduce the risk of sudden cardiac arrest and improve clinical outcome.
机译:大规模肺栓塞(PE)患者越来越多地利用静脉动脉体外膜氧合(ECMO)。然而,疗效和安全性仍然不确定。本研究旨在调查急性PE患者患有Ecmo治疗患者的临床疗程和结果。回顾性分析了2012年1月至2019年12月救援的二十一名急性体育病患者。审查了这些患者的临床特征,实验室生物标志物和成像结果,并研究了与即时结果和临床课程的关系。十六名患者(76.2%)经历了在血管生成休克发生后2μl中的耐火循环塌陷,需要在2℃内进行心肺复苏(CPR)或ECMO载体,并且在ECMO启动之前,无可以接受明确的再灌注治疗。在ECMO支持之前或期间,超过90%的患者患有右心室(RV)功能障碍的成像迹象。在常规患者中,与心肌肌钙蛋白I水平相比,计算断层扫描(CT)值是快速疾病进展的有价值预测因子。最终,在医院死亡发生在10名患者(47.6%)和90%的患者中死于延长的CPR相关的脑死亡。心脏骤停是预后差的重要预测因子(P?= 0.001)。 ECMO似乎是大量PE患者安全有效的循环支持。 RV功能障碍患者建议在重症监护室中密切监测,并积极地使用ECMO,可能会降低心脏骤停的风险,并改善临床结果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号